ADVERTISEMENT

Dr. Reddy's Labs - U.S., Europe To Drive Growth: Nirmal Bang

The US market has demonstrated growth in both base business as well as limited volume launches such as Lenalidomide (Revlimid).

<div class="paragraphs"><p>Picture for representation (Source: Dr Reddy's Laboratories/X)</p></div>
Picture for representation (Source: Dr Reddy's Laboratories/X)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit